Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (002932) — Strategic Asset Allocation Index
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (002932) has a Strategic Asset Allocation Index of 9.0% as of September 2023. Strategic assets (PP&E of CN¥576.74 Million plus long-term investments of CN¥-) total CN¥576.74 Million, measured against net assets of CN¥6.39 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check 002932 cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A Strategic Asset Allocation Index (2015–2022)
This chart shows how Wuhan Easy Diagnosis Biomedicine Co Ltd Class A's Strategic Asset Allocation Index has evolved across 8 annual periods from 2015 to 2022. As of September 2023, the index stands at 9.0%, representing strategic assets of CN¥576.74 Million against net assets of CN¥6.39 Billion CNY. See Wuhan Easy Diagnosis Biomedicine Co Ltd free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (2015–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Wuhan Easy Diagnosis Biomedicine Co Ltd Class A from 2015 to 2022, covering 8 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see 002932 stock market capitalisation.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 7.8% | CN¥525.97 Million | CN¥525.97 Million | CN¥- | CN¥6.77 Billion | ▼ -0.8 pp |
| 2021 | 8.5% | CN¥243.47 Million | CN¥243.47 Million | CN¥- | CN¥2.85 Billion | ▼ -2.5 pp |
| 2020 | 11.1% | CN¥123.26 Million | CN¥123.26 Million | CN¥- | CN¥1.11 Billion | ▼ -4.7 pp |
| 2019 | 15.8% | CN¥97.26 Million | CN¥97.26 Million | CN¥- | CN¥615.62 Million | ▲ +0.6 pp |
| 2018 | 15.2% | CN¥90.02 Million | CN¥90.02 Million | CN¥- | CN¥592.59 Million | ▼ -13.5 pp |
| 2017 | 28.7% | CN¥69.66 Million | CN¥69.66 Million | CN¥- | CN¥242.93 Million | ▲ +1.8 pp |
| 2016 | 26.9% | CN¥47.12 Million | CN¥47.12 Million | CN¥- | CN¥175.08 Million | ▲ +16.2 pp |
| 2015 | 10.7% | CN¥12.38 Million | CN¥12.38 Million | CN¥- | CN¥115.39 Million | — |